Board approves Senior Executive ESOP 2026 and Employee ESOP 2026; options up to 26,50,000 and 47,00,000 shares

Bliss GVS Pharma's board met on Thursday, October 01, 2026 and approved two employee stock option schemes 👔.

Thu 1 Oct 2026

Senior Executive ESOP 2026 - max shares

not exercisable into more than 26,50,000 equity shares, ~2.49% of paid-up equity share capital on a fully diluted basis

Employee ESOP 2026 - max shares

not exercisable into more than 47,00,000 equity shares, ~4.42% on a fully diluted basis

Exercise price

discounted fixed price of INR 10/- for each option

Vesting period

Minimum one (1) year between grant and vesting

Board meeting date

Thursday, October 01, 2026

What the board approved

Bliss GVS Pharma's board of directors met on Thursday, October 01, 2026 through video conferencing or other audio visual means. Based on the recommendation of the Nomination and Remuneration Committee, and subject to the approval of the shareholders and other applicable approvals, the board considered and approved:

• Adoption of Bliss GVS Pharma Limited - Senior Executive Employee Stock Option Policy 2026 ("Senior Executive ESOP 2026")
• Adoption of Bliss GVS Pharma Limited - Employee Stock Option Policy 2026 ("Employee ESOP 2026")
• Grant of stock options equal to or exceeding 1% of issued capital to identified employees during any one year

What an ESOP is

An employee stock option gives an employee the right to buy a share of the company later, at a price fixed in advance. Here, that pre-set exercise price is a discounted fixed price of INR 10/- for each option under both schemes. The option becomes usable only after it vests, and both schemes carry a minimum period of one (1) year between grant of options and vesting of options.

The numbers

• Senior Executive ESOP 2026: the aggregate number of stock options proposed to be granted shall not be exercisable into more than 26,50,000 equity shares, corresponding to ~2.49% of the paid-up equity share capital, on a fully diluted basis, in one or more tranches.
• Employee ESOP 2026: the aggregate number of stock options proposed to be granted shall not be exercisable into more than 47,00,000 equity shares, corresponding to ~4.42% of the paid-up equity share capital, on a fully diluted basis, in one or more tranches.
• Exercise price for each option under both schemes: a discounted fixed price of INR 10/-.

How the schemes will run

• Both schemes will be administered by the Nomination and Remuneration Committee, which will function as the Compensation Committee for the purposes of the schemes.
• Both schemes will be implemented through the issuance of new equity shares by the company.
• The grant of stock options will be made to eligible employees in accordance with the eligibility criteria prescribed under each scheme.
• The granted options, once vested, will entitle the option holder to acquire an equal number of equity shares, upon payment of the exercise price and applicable taxes, in accordance with the terms and conditions of the scheme.

Status of the approval

The board's decision is subject to the approval of the shareholders of the company and such other statutory and regulatory approvals as may be applicable. In the disclosures attached for the two schemes, the columns for options vested, options exercised, money realised by exercise of options, the total number of shares arising as a result of exercise of options, options lapsed, variation of terms of options, subsequent changes or cancellation or exercise of such options, and diluted earnings per share pursuant to issue of equity shares on exercise of options are shown as "Not Applicable", as the outcome pertains to approval of the scheme by the board of directors.

The meeting commenced at 15:37 p.m. and concluded at 16:55 p.m.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.